Clinical trials
Lung cancer requires expert care. Our multidisciplinary team is here to help.
Call now
(352) 265-0535
Radiation Oncology
Schedule appointment
-
COMM-LCS: Evaluating multi-level communication strategies to enhance lung cancer screening -
TAPUR: Testing FDA Approved Drugs That Target Specific Abnormal Tumor Genes in Pts w/Advanced Cancer The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. Note: Due to…
- Investigator
- Thomas J George
- Ages
- 12 Years - N/A
- Sexes
- All
-
Phase 2 Study of ABBV-706 in Combination With Atezolizumab Versus SOC as 1L Treatment in ES-SCLC Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, and brain. The purpose of this study is to assess…
- Investigator
- Aline Fares
- Ages
- 18 Years - N/A
- Sexes
- All
-
Ph3 -Controlled Study of Adjuvant Intismeran Autogene Plus Subcutaneous Pembro / MK-3475A Researchers are looking for new ways to treat high-risk, localized non-small cell lung cancer (NSCLC) that has been removed with surgery. People with high-risk, localized NSCLC are often treated with surgery. Researchers want to learn if…
- Investigator
- Aline Fares
- Ages
- 18 Years - N/A
- Sexes
- All